Koninklijke Philips N.V. (RYLPF)
USD 24.63
(0.28%)
USD 24.63
(0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.04 Billion EUR | -30.35% |
| 2022 | 115 Million EUR | -26.44% |
| 2021 | 1.99 Billion EUR | -37.15% |
| 2020 | 2.85 Billion EUR | 1.58% |
| 2019 | 2.8 Billion EUR | 10.78% |
| 2018 | 2.79 Billion EUR | 6.81% |
| 2017 | 2.64 Billion EUR | -17.16% |
| 2016 | 2.35 Billion EUR | 36.15% |
| 2015 | 1.75 Billion EUR | 32.46% |
| 2014 | 1.78 Billion EUR | -47.93% |
| 2013 | 3.1 Billion EUR | 33.83% |
| 2012 | 1.94 Billion EUR | 1.06% |
| 2011 | 1.03 Billion EUR | -31.32% |
| 2010 | 3.63 Billion EUR | 60.36% |
| 2009 | 2.3 Billion EUR | 251.83% |
| 2008 | 656 Million EUR | 764.2% |
| 2007 | 2.7 Billion EUR | -106.33% |
| 2006 | 2.01 Billion EUR | -45.12% |
| 2005 | 2.26 Billion EUR | -26.76% |
| 2004 | 2.6 Billion EUR | 24.08% |
| 2003 | 2.9 Billion EUR | -37.15% |
| 2002 | 3.1 Billion EUR | 13.73% |
| 2001 | 2.89 Billion EUR | 34.94% |
| 2000 | 6.77 Billion EUR | 2.85% |
| 1999 | 3.65 Billion EUR | 1.91% |
| 1998 | 2.9 Billion EUR | -19.61% |
| 1997 | 3.32 Billion EUR | 25.28% |
| 1996 | 2.25 Billion EUR | 10.83% |
| 1995 | 3.13 Billion EUR | -5.57% |
| 1994 | 3.15 Billion EUR | 48.17% |
| 1993 | 2.56 Billion EUR | -36.65% |
| 1992 | 2.59 Billion EUR | 14.76% |
| 1991 | 2.7 Billion EUR | 3.98% |
| 1990 | 2.6 Billion EUR | 15.1% |
| 1989 | 2.26 Billion EUR | 8.7% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 351 Million EUR | -52.82% |
| 2024 Q2 | 744 Million EUR | 215.26% |
| 2024 Q1 | -800 Million EUR | -1052.68% |
| 2023 Q3 | 221 Million EUR | 10.5% |
| 2023 Q1 | -585 Million EUR | -564.29% |
| 2023 FY | - EUR | -30.35% |
| 2023 Q4 | -56 Million EUR | -125.34% |
| 2023 Q2 | 200 Million EUR | 134.19% |
| 2022 Q2 | 34 Million EUR | 119.43% |
| 2022 Q3 | -85 Million EUR | -350.0% |
| 2022 Q4 | 126 Million EUR | 248.24% |
| 2022 FY | - EUR | -26.44% |
| 2022 Q1 | -175 Million EUR | -192.59% |
| 2021 Q3 | 393 Million EUR | 222.13% |
| 2021 Q2 | 122 Million EUR | 1625.0% |
| 2021 FY | - EUR | -37.15% |
| 2021 Q4 | 189 Million EUR | -51.91% |
| 2021 Q1 | -8 Million EUR | -100.96% |
| 2020 FY | - EUR | 1.58% |
| 2020 Q4 | 834 Million EUR | 67.47% |
| 2020 Q1 | 73 Million EUR | -90.28% |
| 2020 Q2 | 306 Million EUR | 319.18% |
| 2020 Q3 | 498 Million EUR | 62.75% |
| 2019 Q4 | 751 Million EUR | 120.23% |
| 2019 FY | - EUR | 10.78% |
| 2019 Q1 | 294 Million EUR | -62.21% |
| 2019 Q2 | 394 Million EUR | 34.01% |
| 2019 Q3 | 341 Million EUR | -13.45% |
| 2018 Q3 | 459 Million EUR | 45.71% |
| 2018 Q4 | 778 Million EUR | 69.5% |
| 2018 Q2 | 315 Million EUR | 46.51% |
| 2018 FY | - EUR | 6.81% |
| 2018 Q1 | 215 Million EUR | -71.45% |
| 2017 Q3 | 351 Million EUR | 25.36% |
| 2017 FY | - EUR | -17.16% |
| 2017 Q4 | 753 Million EUR | 114.53% |
| 2017 Q2 | 280 Million EUR | -24.73% |
| 2017 Q1 | 372 Million EUR | -69.0% |
| 2016 Q4 | 1.2 Billion EUR | 50.0% |
| 2016 Q2 | 690 Million EUR | 28.25% |
| 2016 Q1 | 538 Million EUR | -0.92% |
| 2016 FY | - EUR | 36.15% |
| 2016 Q3 | 800 Million EUR | 15.94% |
| 2015 Q4 | 543 Million EUR | -18.59% |
| 2015 Q2 | 708 Million EUR | 56.29% |
| 2015 Q3 | 667 Million EUR | -5.79% |
| 2015 FY | - EUR | 32.46% |
| 2015 Q1 | 453 Million EUR | -21.08% |
| 2014 FY | - EUR | -47.93% |
| 2014 Q3 | 291 Million EUR | -54.88% |
| 2014 Q2 | 645 Million EUR | 18.35% |
| 2014 Q1 | 545 Million EUR | -53.14% |
| 2014 Q4 | 574 Million EUR | 97.25% |
| 2013 Q2 | 838 Million EUR | 33.44% |
| 2013 Q1 | 628 Million EUR | 76.9% |
| 2013 Q4 | 1.16 Billion EUR | 43.76% |
| 2013 Q3 | 809 Million EUR | -3.46% |
| 2013 FY | - EUR | 33.83% |
| 2012 Q4 | 355 Million EUR | -51.7% |
| 2012 Q3 | 735 Million EUR | 10.19% |
| 2012 Q2 | 667 Million EUR | 4.38% |
| 2012 FY | - EUR | 1.06% |
| 2012 Q1 | 639 Million EUR | 143.89% |
| 2011 Q1 | 728 Million EUR | -36.64% |
| 2011 Q3 | 593 Million EUR | -1.0% |
| 2011 Q4 | 262 Million EUR | -55.82% |
| 2011 FY | - EUR | -31.32% |
| 2011 Q2 | 599 Million EUR | -17.72% |
| 2010 Q1 | 738 Million EUR | -26.27% |
| 2010 FY | - EUR | 60.36% |
| 2010 Q4 | 1.14 Billion EUR | 10.06% |
| 2010 Q3 | 1.04 Billion EUR | 35.58% |
| 2010 Q2 | 770 Million EUR | 4.34% |
| 2009 Q4 | 1 Billion EUR | 57.89% |
| 2009 FY | - EUR | 251.83% |
| 2009 Q1 | 243 Million EUR | -59.99% |
| 2009 Q2 | 430 Million EUR | 76.95% |
| 2009 Q3 | 634 Million EUR | 47.44% |
| 2008 Q4 | 607.3 Million EUR | 160.56% |
| 2008 Q1 | 437.53 Million EUR | 126.8% |
| 2008 Q2 | 485.11 Million EUR | 10.87% |
| 2008 Q3 | 233.07 Million EUR | -51.95% |
| 2008 FY | - EUR | 764.2% |
| 2007 Q3 | 565.11 Million EUR | 9.23% |
| 2007 FY | - EUR | -106.33% |
| 2007 Q1 | 500.03 Million EUR | -12.46% |
| 2007 Q2 | 517.37 Million EUR | 3.47% |
| 2007 Q4 | -1.63 Billion EUR | -388.92% |
| 2006 FY | - EUR | -45.12% |
| 2006 Q4 | 571.19 Million EUR | 4430.64% |
| 2006 Q3 | 12.6 Million EUR | -98.08% |
| 2006 Q2 | 657.82 Million EUR | 10.13% |
| 2006 Q1 | 597.3 Million EUR | -35.73% |
| 2005 Q1 | 613.28 Million EUR | -62.26% |
| 2005 Q3 | 734.49 Million EUR | 29.83% |
| 2005 Q2 | 565.71 Million EUR | -7.76% |
| 2005 Q4 | 929.39 Million EUR | 26.54% |
| 2005 FY | - EUR | -26.76% |
| 2004 FY | - EUR | 24.08% |
| 2004 Q2 | 819.54 Million EUR | 35.17% |
| 2004 Q3 | 830.8 Million EUR | 1.37% |
| 2004 Q4 | 1.62 Billion EUR | 95.61% |
| 2004 Q1 | 606.31 Million EUR | -48.85% |
| 2003 Q2 | 572.44 Million EUR | 10.13% |
| 2003 Q3 | 646.47 Million EUR | 27.25% |
| 2003 Q4 | 1.11 Billion EUR | 52.76% |
| 2003 FY | - EUR | -37.15% |
| 2003 Q1 | 567.45 Million EUR | -61.79% |
| 2002 Q4 | 1.13 Billion EUR | 58.3% |
| 2002 Q2 | 590.48 Million EUR | 8.58% |
| 2002 Q1 | 592 Million EUR | -74.4% |
| 2002 FY | - EUR | 13.73% |
| 2002 Q3 | 614.75 Million EUR | 86.52% |
| 2001 Q3 | 230.03 Million EUR | 1263.21% |
| 2001 Q1 | 920.08 Million EUR | -67.38% |
| 2001 Q2 | 16.87 Million EUR | -98.17% |
| 2001 Q4 | 1.76 Billion EUR | 667.58% |
| 2001 FY | - EUR | 34.94% |
| 2000 Q4 | 2.82 Billion EUR | 198.33% |
| 2000 Q3 | 1.01 Billion EUR | 30.33% |
| 2000 Q2 | 780 Million EUR | 9.36% |
| 2000 Q1 | 663.35 Million EUR | -54.22% |
| 2000 FY | - EUR | 2.85% |
| 1999 Q4 | 1.44 Billion EUR | 312.06% |
| 1999 Q1 | 549 Million EUR | 1292.49% |
| 1999 Q2 | 318.74 Million EUR | -41.94% |
| 1999 FY | - EUR | 1.91% |
| 1999 Q3 | 351.66 Million EUR | 10.33% |
| 1998 Q2 | 438.07 Million EUR | 14.24% |
| 1998 Q4 | -46.03 Million EUR | -120.09% |
| 1998 FY | - EUR | -19.61% |
| 1998 Q1 | 383.47 Million EUR | -54.28% |
| 1998 Q3 | 229.1 Million EUR | -47.7% |
| 1997 Q3 | 532.1 Million EUR | 1.94% |
| 1997 FY | - EUR | 25.28% |
| 1997 Q1 | 383.62 Million EUR | 101.81% |
| 1997 Q2 | 521.97 Million EUR | 36.06% |
| 1997 Q4 | 838.73 Million EUR | 57.62% |
| 1996 FY | - EUR | 10.83% |
| 1996 Q4 | -21.17 Billion EUR | -383.23% |
| 1996 Q3 | 7.47 Billion EUR | -2.14% |
| 1996 Q2 | 7.63 Billion EUR | 0.82% |
| 1996 Q1 | 7.57 Billion EUR | 138.56% |
| 1995 Q2 | 7.05 Billion EUR | 5.97% |
| 1995 Q3 | 7.33 Billion EUR | 4.07% |
| 1995 FY | - EUR | -5.57% |
| 1995 Q4 | -19.65 Billion EUR | -367.82% |
| 1995 Q1 | 6.65 Billion EUR | 133.8% |
| 1994 Q2 | 7.33 Billion EUR | -3.48% |
| 1994 Q3 | 7.1 Billion EUR | -3.08% |
| 1994 Q4 | -19.68 Billion EUR | -376.93% |
| 1994 FY | - EUR | 48.17% |
| 1994 Q1 | 7.59 Billion EUR | 141.66% |
| 1993 Q3 | 6.44 Billion EUR | -1.44% |
| 1993 FY | - EUR | -36.65% |
| 1993 Q2 | 6.53 Billion EUR | 3.64% |
| 1993 Q1 | 6.3 Billion EUR | 139.1% |
| 1993 Q4 | -18.23 Billion EUR | -383.1% |
| 1992 Q3 | 6.03 Billion EUR | -3.4% |
| 1992 FY | - EUR | 14.76% |
| 1992 Q1 | 5.62 Billion EUR | 132.27% |
| 1992 Q4 | -16.13 Billion EUR | -367.33% |
| 1992 Q2 | 6.24 Billion EUR | 10.99% |
| 1991 Q4 | -17.44 Billion EUR | -308.23% |
| 1991 Q1 | 1.59 Billion EUR | 109.4% |
| 1991 Q2 | 5.84 Billion EUR | 265.85% |
| 1991 Q3 | 8.37 Billion EUR | 43.37% |
| 1991 FY | - EUR | -39.81% |
| 1990 Q4 | -16.98 Billion EUR | -335.87% |
| 1990 Q2 | 5.85 Billion EUR | 3.15% |
| 1990 Q1 | 5.67 Billion EUR | 134.83% |
| 1990 Q3 | 7.19 Billion EUR | 22.89% |
| 1990 FY | - EUR | 153.69% |
| 1989 Q1 | 5.22 Billion EUR | 128.92% |
| 1989 Q2 | 5.81 Billion EUR | 11.32% |
| 1989 FY | - EUR | 5.81% |
| 1989 Q3 | 5.82 Billion EUR | 0.04% |
| 1989 Q4 | -16.3 Billion EUR | -380.17% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Avitar, Inc. | -1.66 Million USD | 62517.444% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 89532.99% |
| Urologix, Inc. | -6.34 Million USD | 16509.206% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 202619.333% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 165552.658% |
| CVR Medical Corp. | - USD | -Infinity% |
| Össur hf. | 137.38 Million USD | -657.747% |
| Össur hf. | 137.38 Million USD | -657.747% |
| SS Innovations International, Inc. | -20.37 Million USD | 5208.954% |
| VMS Rehab Systems, Inc. | -68.55 USD | 1518599662.363% |
| QHSLab, Inc. | -91.29 Thousand USD | 1140384.578% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| BrainsWay Ltd. | -2.31 Million USD | 45145.435% |
| BioElectronics Corporation | -274.29 Thousand USD | 379625.32% |
| Hamilton Thorne Ltd. | 5.52 Million USD | -18753.146% |
| Theraclion SA | -2.05 Million USD | 50861.025% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.45 Million USD | 71786.76% |
| Stratec SE | 39.91 Million USD | -2508.107% |
| AVITA Medical, Inc. | -39.56 Million USD | 2730.93% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 880371.269% |
| Zecotek Photonics Inc. | -3.44 Million USD | 30342.12% |
| Wellstar International, Inc. | -1.35 Million USD | 76840.596% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | -10550.605% |
| Escalon Medical Corp. | -58.46 Thousand USD | 1780774.296% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 33401.344% |
| Aurora Spine Corporation | -454.37 Thousand USD | 229204.402% |
| NewCardio, Inc. | -9.37 Million USD | 11198.877% |
| Vivos Inc. | -2.79 Million USD | 37369.803% |
| MicroPort Scientific Corporation | -347.57 Million USD | 399.501% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 526679.359% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 62489.35% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 274838.326% |
| Nanomix Corporation | -8.13 Million USD | 12889.064% |
| IR-Med Inc. | -4.89 Million USD | 21379.64% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 147335.619% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 60556.999% |
| Lombard Medical, Inc. | -28.06 Million USD | 3808.85% |
| ALR Technologies Inc. | -6.4 Million USD | 16364.824% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -1031175.076% |
| Heart Tronics, Inc. | -14.85 Million USD | 7106.856% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 7940.717% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 11474.564% |
| Ingen Technologies, Inc. | -8639.00 USD | 12050105.788% |
| United American Healthcare Corporation | -59 Thousand USD | 1764506.78% |
| Odyssey Group International, Inc. | -2.13 Million USD | 48788.68% |
| ECGI Holdings, Inc. | -2.99 Million USD | 34911.024% |
| Polarean Imaging plc | -11.19 Million USD | 9398.802% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -228159.44% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 84094.897% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 136006.638% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 467297.444% |
| Smith & Nephew plc | 1 Billion USD | -3.831% |
| NIOX Group Plc | 11.07 Million USD | -9299.464% |
| Fuse Medical, Inc. | 1.83 Million USD | -56620.478% |
| Broncus Holding Corporation | -25.19 Million USD | 4231.147% |
| Brain Scientific Inc. | -7.93 Million USD | 13221.199% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 11185.195% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 5657708.696% |